Evotec Signs an Agreement with Sanofi for Novel Drug Development
Shots:
- Sanofi and Evotec launches BRIDGE LAB031- designed to convert academic research into drug discovery candidates for multiple therapeutic areas. BRIDGE is a public-private partnership combining academia- biotech and venture capital into pharma for early-stage projects
- The companies will focus on development of multiple small molecule programmes through lead optimization for next three years
- Evotec will develop and generate multiple lead candidates for Sanofi and apply its technologies to the projects for expedited drug discovery and development. Sanofi has an option to acquire development rights of products on expected milestone criteria
Ref: Evotec | Image: Handelsblatt
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com